RankingsPricing
  1. JP-listed companies
  2. Human Metabolome Technologies, Inc.
  3. Financials
  4. Stockholders' equity

Human Metabolome Technologies, Inc.JP:6090

Market cap
¥3.9B
P/E ratio
14.4x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Jun 30, 20251,909-1.96%
Jun 30, 20241,947+9.84%
Jun 30, 20231,772+19.22%
Jun 30, 20221,487+17.97%
Jun 30, 20211,260+3.69%
Jun 30, 20201,215+0.07%
Jun 30, 20191,214-15.49%
Mar 31, 20191,437-18.01%
Mar 31, 20181,753-5.74%
Mar 31, 20171,859+22.07%
Mar 31, 20161,523-3.77%
Mar 31, 20151,583+2.25%
Mar 31, 20141,548

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)